Cargando…

The Anti-Atherosclerosis Effect of Anakinra, a Recombinant Human Interleukin-1 Receptor Antagonist, in Apolipoprotein E Knockout Mice

Interleukin (IL)-1β plays an important role in atherosclerosis pathogenesis. We aimed to investigate the effect of anakinra, a recombinant human IL-1 receptor antagonist, on the progression of atherosclerosis in apolipoprotein E knockout (ApoE(–/–)) mice. ApoE(–/–) mice (8-week male) were treated wi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ku, Eu Jeong, Kim, Bo-Rahm, Lee, Jee-In, Lee, Yun Kyung, Oh, Tae Jung, Jang, Hak C., Choi, Sung Hee
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9104865/ https://www.ncbi.nlm.nih.gov/pubmed/35563294 http://dx.doi.org/10.3390/ijms23094906

Ejemplares similares

Interleukin-1 Antagonist Anakinra in Amyotrophic Lateral Sclerosis—A Pilot Study
por: Maier, André, et al.
Publicado: (2015)

Cerebral autoinflammatory disease treated with anakinra
por: Jang, Yoonhyuk, et al.
Publicado: (2018)

The Influence of Trehalose on Atherosclerosis and Hepatic Steatosis in Apolipoprotein E Knockout Mice
por: Stachowicz, Aneta, et al.
Publicado: (2019)

The interleukin-1 receptor antagonist anakinra improves endothelial dysfunction in streptozotocin-induced diabetic rats
por: Vallejo, Susana, et al.
Publicado: (2014)

Interleukin-1 receptor antagonist anakinra in association with remdesivir in severe COVID-19: A case report
por: Franzetti, Marco, et al.
Publicado: (2020)

Association with inflammatory cells and apolipoproteins to the progression of atherosclerosis
por: Eo, Hyun-Seon, et al.
Publicado: (2011)

The membrane attack complex of complement drives the progression of atherosclerosis in apolipoprotein E knockout mice
por: Lewis, Ruth D., et al.
Publicado: (2010)

Anakinra treatment for refractory cerebral autoinflammatory responses
por: Jang, Yoonhyuk, et al.
Publicado: (2022)

Ocular modifications in a young girl with cryopyrin-associated periodic syndromes responding to interleukin-1 receptor antagonist anakinra
por: Terrada, Celine, et al.
Publicado: (2011)

The Safety and Efficacy of Anakinra, an Interleukin-1 Antagonist in Severe Cases of COVID-19: A Systematic Review and Meta-Analysis
por: Somagutta, Manoj Kumar Reddy, et al.
Publicado: (2021)

Towards a Treatment for Neuroinflammation in Epilepsy: Interleukin-1 Receptor Antagonist, Anakinra, as a Potential Treatment in Intractable Epilepsy
por: Yamanaka, Gaku, et al.
Publicado: (2021)

Anakinra Pilot – a clinical trial to demonstrate safety, feasibility and pharmacokinetics of interleukin 1 receptor antagonist in preterm infants
por: Green, Elys A., et al.
Publicado: (2022)

Choline Supplementation Does Not Promote Atherosclerosis in CETP-Expressing Male Apolipoprotein E Knockout Mice
por: Collins, Heidi L., et al.
Publicado: (2022)

Discovery of plasma biomarkers for predicting the severity of coronary artery atherosclerosis by quantitative proteomics
por: Ku, Eu Jeong, et al.
Publicado: (2020)

Pravastatin and Sarpogrelate Synergistically Ameliorate Atherosclerosis in LDLr-Knockout Mice
por: Park, Kyung-Yeon, et al.
Publicado: (2016)

No Significant Role for Smooth Muscle Cell Mineralocorticoid Receptors in Atherosclerosis in the Apolipoprotein-E Knockout Mouse Model
por: Moss, M. Elizabeth, et al.
Publicado: (2018)

Skeletal Muscle-specific PGC-1α Overexpression Suppresses Atherosclerosis in Apolipoprotein E-Knockout Mice
por: Shimba, Yuki, et al.
Publicado: (2019)

Recurrent poliserositis succesfully treated with IL-1 receptor antagonist Anakinra
por: Lovillo, MS Camacho, et al.
Publicado: (2011)

Apolipoprotein B and interleukin 1 receptor antagonist: reversing the risk of coronary heart disease
por: Yang, Fangkun, et al.
Publicado: (2023)

Peri- and Postoperative Treatment with the Interleukin-1 Receptor Antagonist Anakinra Is Safe in Patients Undergoing Renal Transplantation: Case Series and Review of the Literature
por: Mulders-Manders, Catharina M., et al.
Publicado: (2017)

Hypoxanthine induces cholesterol accumulation and incites atherosclerosis in apolipoprotein E‐deficient mice and cells
por: Ryu, Hye‐Myung, et al.
Publicado: (2016)

Atherosclerosis affects calcium signalling in endothelial cells from apolipoprotein E knockout mice before plaque formation
por: Prendergast, Clodagh, et al.
Publicado: (2014)

Deletion of the Mir-106b~ 25 MicroRNA cluster attenuates atherosclerosis in Apolipoprotein E knockout mice
por: Semo, Jonathan, et al.
Publicado: (2019)

Inhibition of the Ubiquitin-Activating Enzyme UBA1 Suppresses Diet-Induced Atherosclerosis in Apolipoprotein E-Knockout Mice
por: Liao, Jiawei, et al.
Publicado: (2020)

Prediction of the Network Pharmacology-Based Mechanism for Attenuation of Atherosclerosis in Apolipoprotein E Knockout Mice by Panax notoginseng Saponins
por: Long, Linzi, et al.
Publicado: (2020)

The anti-inflammatory effects of exercise training promote atherosclerotic plaque stabilization in apolipoprotein E knockout mice with diabetic atherosclerosis
por: Kadoglou, N.P.E., et al.
Publicado: (2013)

Increased mTORC1 activity contributes to atherosclerosis in apolipoprotein E knockout mice and in vascular smooth muscle cells()
por: Ma, Kun Ling, et al.
Publicado: (2013)

Mitochondrial Aldehyde Dehydrogenase Activation by Alda‐1 Inhibits Atherosclerosis and Attenuates Hepatic Steatosis in Apolipoprotein E‐Knockout Mice
por: Stachowicz, Aneta, et al.
Publicado: (2014)

MicroRNA-134 Promotes the Development of Atherosclerosis Via the ANGPTL4/LPL Pathway in Apolipoprotein E Knockout Mice
por: Ye, Qiong, et al.
Publicado: (2018)

Apple Supplementation Improves Hemodynamic Parameter and Attenuates Atherosclerosis in High-Fat Diet-Fed Apolipoprotein E-Knockout Mice
por: Soleti, Raffaella, et al.
Publicado: (2020)

Intestine-specific DGAT1 deficiency improves atherosclerosis in apolipoprotein E knockout mice by reducing systemic cholesterol burden
por: Vujić, Nemanja, et al.
Publicado: (2020)

PReS-FINAL-2333: Long term efficacy of interleukin-1 receptor antagonist (anakinra) in a multicentric cohort of patients affected by idiopathic recurrent pericarditis
por: Finetti, M, et al.
Publicado: (2013)

Successful treatment of cytomegalovirus associated hemophagocytic lymphohistiocytosis with the interleukin 1 inhibitor – anakinra
por: Divithotawela, Chandima, et al.
Publicado: (2015)

The IL-1 Antagonist Anakinra Attenuates Glioblastoma Aggressiveness by Dampening Tumor-Associated Inflammation
por: Hübner, Max, et al.
Publicado: (2020)

Simvastatin and Losartan Differentially and Synergistically Inhibit Atherosclerosis in Apolipoprotein E(-/-) Mice
por: Lee, Bok-Soo, et al.
Publicado: (2012)

Modest vasomotor dysfunction induced by low doses of C(60 )fullerenes in apolipoprotein E knockout mice with different degree of atherosclerosis
por: Vesterdal, Lise K, et al.
Publicado: (2009)

The DPP-4 inhibitor sitagliptin attenuates the progress of atherosclerosis in apolipoprotein-E-knockout mice via AMPK- and MAPK-dependent mechanisms
por: Zeng, Yanmei, et al.
Publicado: (2014)

Atherosclerosis differentially affects calcium signalling in endothelial cells from aortic arch and thoracic aorta in Apolipoprotein E knockout mice
por: Prendergast, Clodagh, et al.
Publicado: (2014)

Anakinra, an interleukin-1 receptor antagonist, increases the morphine analgesic effect and decreases morphine tolerance development by modulating oxidative stress and endoplasmic reticulum stress in rats
por: AVCI, Onur, et al.
Publicado: (2020)

LJ-1888, a selective antagonist for the A3 adenosine receptor, ameliorates the development of atherosclerosis and hypercholesterolemia in apolipoprotein E knock-out mice
por: Park, Jong-Gil, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_5rr4pcg2ck9nuqt8mro00r0qao